Aron Shapiro

Company: VeraDermics

Job title: Vice President - Clinical Development & Regulatory Affairs

Seminars:

Veradermics Pattern Hairloss Studies: Efficacy Endpoints with Validated Imaging Tools 1:30 pm

Founded by practicing dermatologists, ensuring clinical relevance and patient-centered innovation VDPHL: A novel, non-hormonal oral investigational drug targeting androgenetic alopecia (AGA) that could offer a differentiated safety and efficacy profile High quality, standardized, reproducible imaging builds confidence for quality oversight and quantitative measurements for regulatory endpoints submissionRead more

day: Day One PM